The result suggested the significant down-regulation of ZFP36L1 in superficial and muscle-invasive bladder cancer (MIBC), respectively, and but not in the carcinoma in situ (CIS) (Figure 1C). The gene discussed is ZFP36L1; the disease is in situ carcinoma.